We are live on
!
Find out more
PHS
PFM Health Sciences Portfolio holdings
AUM
$1.1B
1-Year Est. Return
57.92%
This Fund
S&P 500
This Quarter
Est. Return
-0.97%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$3.55B
AUM Growth
+$133M
(+3.9%)
Cap. Flow
+$228M
Cap. Flow
% of AUM
6.44%
Top 10 Holdings %
Top 10 Hldgs %
31.71%
Holding
123
New
40
Increased
24
Reduced
23
Closed
30
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elevance Health
ELV
|
+$71.8M |
| 2 |
AbbVie
ABBV
|
+$63.8M |
| 3 |
Cigna
CI
|
+$62.3M |
| 4 |
Puma Biotechnology
PBYI
|
+$49.5M |
| 5 |
UnitedHealth
UNH
|
+$44.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$99.2M |
| 2 |
Meta Platforms (Facebook)
META
|
+$73.1M |
| 3 |
Baxter International
BAX
|
+$70M |
| 4 |
ServiceNow
NOW
|
+$67.7M |
| 5 |
Visa
V
|
+$65.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 40.7% |
| 2 | Technology | 6.07% |
| 3 | Energy | 6.01% |
| 4 | Industrials | 3.89% |
| 5 | Communication Services | 3.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Icon
ICLR
$13.9B
| – | – |
-195,089
| Closed | -$15.1M |
|
102
CALL
Ionis Pharmaceuticals
IONS
$9.14B
| – | – |
-349,800
| Closed | -$12.8M |
|
103
CALL
Eli Lilly
LLY
$1.09T
| – | – |
-486,200
| Closed | -$39M |
|
104
Merck
MRK
$326B
| – | – |
-495,871
| Closed | -$29.5M |
|
105
Micron Technology
MU
$927B
| – | – |
-2,484,920
| Closed | -$44.2M |
|
|
106
ServiceNow
NOW
$114B
| – | – |
-4,274,095
| Closed | -$67.7M |
|
107
PUT
Regeneron Pharmaceuticals
REGN
$72.9B
| – | – |
-27,800
| Closed | -$11.2M |
|
108
Sonida Senior Living
SNDA
$2.04B
| – | – |
-7,638
| Closed | -$1.93M |
|
109
Starwood Property Trust
STWD
$6.18B
| – | – |
-973,151
| Closed | -$21.9M |
|
|
110
Visa
V
$697B
| – | – |
-792,535
| Closed | -$65.5M |
|
111
Vipshop
VIPS
$7.13B
| – | – |
-3,283,961
| Closed | -$48.2M |
|
|
PXD
112
DELISTED
Pioneer Natural Resource Co.
PXD
| – | – |
-349,564
| Closed | -$64.9M |
|
|
SPLK
113
DELISTED
Splunk Inc
SPLK
| – | – |
-653,872
| Closed | -$38.4M |
|
|
HRC
114
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| – | – |
-125,276
| Closed | -$7.76M |
|
|
MDCO
115
CALL
DELISTED
Medicines Co
MDCO
| – | – |
-293,900
| Closed | -$11.1M |
|
|
DMTX
116
DELISTED
Dimension Therapeutics, Inc
DMTX
| – | – |
-446,003
| Closed | -$3.56M |
|
Similar funds
DAM
MAM
LCM
PRS
DAM
KCM
CF
MIA
PFM Health Sciences's Q4 2016 Portfolio in Review
As of Q4 2016, PFM Health Sciences held 123 positions worth $3.55B, up 3.9% from $3.42B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
PFM Health Sciences deployed $228M of net new capital in Q4 2016, opening 40 new positions and adding to 24 existing holdings. Its largest new stake was Elevance Health: 536,457 shares worth $77.1M.
By sector, the portfolio is most concentrated in Healthcare at 41% of assets, up from 37% a quarter earlier, followed by Technology and Energy.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $73.1M trimmed.
- PFM Health Sciences's largest Q4 2016 buy was Elevance Health: 536,457 shares worth $77.1M.
- PFM Health Sciences added most to AbbVie in Q4 2016, an estimated $63.8M increase.
- PFM Health Sciences's biggest Q4 2016 reduction was Meta Platforms (Facebook), cutting an estimated $73.1M.
- PFM Health Sciences fully exited Apple in Q4 2016, selling an estimated $99.2M.
- PFM Health Sciences's ten largest holdings make up 32% of its $3.55B portfolio in Q4 2016.
- PFM Health Sciences opened 40 new positions and closed 30 in Q4 2016.
- PFM Health Sciences's portfolio value rose 3.9% quarter-over-quarter to $3.55B.
Based on PFM Health Sciences's 13F filing for Q4 2016, filed 14 Feb 2017.